Clinical Trials Browser

Phase 1/2 × Not yet recruiting × camrelizumab × Clear all

NCT06124001 2023-11-15

Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma

Phase 1/2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06010212 2023-08-24

Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell Carcinoma

Phase 1/2 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma